EP4021945A4 - Combinatorial adenine and cytosine dna base editors - Google Patents
Combinatorial adenine and cytosine dna base editors Download PDFInfo
- Publication number
- EP4021945A4 EP4021945A4 EP20857058.0A EP20857058A EP4021945A4 EP 4021945 A4 EP4021945 A4 EP 4021945A4 EP 20857058 A EP20857058 A EP 20857058A EP 4021945 A4 EP4021945 A4 EP 4021945A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- combinatorial
- adenine
- dna base
- base editors
- cytosine dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 title 2
- 229930024421 Adenine Natural products 0.000 title 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 title 1
- 229960000643 adenine Drugs 0.000 title 1
- 229940104302 cytosine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
- C12Y305/04004—Adenosine deaminase (3.5.4.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
- C12Y305/04005—Cytidine deaminase (3.5.4.5)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962894612P | 2019-08-30 | 2019-08-30 | |
US202063023192P | 2020-05-11 | 2020-05-11 | |
PCT/US2020/048825 WO2021042062A2 (en) | 2019-08-30 | 2020-08-31 | Combinatorial adenine and cytosine dna base editors |
Publications (2)
Publication Number | Publication Date |
---|---|
EP4021945A2 EP4021945A2 (en) | 2022-07-06 |
EP4021945A4 true EP4021945A4 (en) | 2023-11-15 |
Family
ID=74683678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20857058.0A Pending EP4021945A4 (en) | 2019-08-30 | 2020-08-31 | Combinatorial adenine and cytosine dna base editors |
Country Status (3)
Country | Link |
---|---|
US (1) | US20220290121A1 (en) |
EP (1) | EP4021945A4 (en) |
WO (1) | WO2021042062A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018165504A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
CN111093714A (en) | 2017-05-25 | 2020-05-01 | 通用医疗公司 | Deamination using a split deaminase to restrict unwanted off-target base editors |
WO2019139645A2 (en) | 2017-08-30 | 2019-07-18 | President And Fellows Of Harvard College | High efficiency base editors comprising gam |
EP3921417A4 (en) | 2019-02-04 | 2022-11-09 | The General Hospital Corporation | Adenine dna base editor variants with reduced off-target rna editing |
WO2020191246A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
WO2021158921A2 (en) * | 2020-02-05 | 2021-08-12 | The Broad Institute, Inc. | Adenine base editors and uses thereof |
GB2614813A (en) | 2020-05-08 | 2023-07-19 | Harvard College | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
KR20240019759A (en) * | 2021-04-21 | 2024-02-14 | 아시모브 인코포레이티드 | Stable production system for adeno-associated virus production |
CN114438110B (en) * | 2022-01-25 | 2023-08-04 | 浙江大学杭州国际科创中心 | Adenine base editor without PAM limitation accurately and construction method thereof |
CN114686456B (en) * | 2022-05-10 | 2023-02-17 | 中山大学 | Base editing system based on bimolecular deaminase complementation and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL264565B1 (en) * | 2016-08-03 | 2024-03-01 | Harvard College | Adenosine nucleobase editors and uses thereof |
EP3601562A1 (en) * | 2017-03-23 | 2020-02-05 | President and Fellows of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
BR112019021719A2 (en) * | 2017-04-21 | 2020-06-16 | The General Hospital Corporation | CPF1 VARIANT (CAS12A) WITH CHANGED PAM SPECIFICITY |
WO2019040650A1 (en) * | 2017-08-23 | 2019-02-28 | The General Hospital Corporation | Engineered crispr-cas9 nucleases with altered pam specificity |
BR112021001904A2 (en) * | 2018-08-03 | 2021-05-04 | Beam Therapeutics Inc. | multi-effect nucleobase editors and methods of using them to modify a target nucleic acid sequence |
EP3921417A4 (en) * | 2019-02-04 | 2022-11-09 | The General Hospital Corporation | Adenine dna base editor variants with reduced off-target rna editing |
-
2020
- 2020-08-31 WO PCT/US2020/048825 patent/WO2021042062A2/en unknown
- 2020-08-31 EP EP20857058.0A patent/EP4021945A4/en active Pending
- 2020-08-31 US US17/638,133 patent/US20220290121A1/en active Pending
Non-Patent Citations (1)
Title |
---|
RINA C. SAKATA ET AL: "A single CRISPR base editor to induce simultaneous C-to-T and A-to-G mutations", BIORXIV, 8 August 2019 (2019-08-08), pages 1 - 17, XP055768028, Retrieved from the Internet <URL:https://www.biorxiv.org/content/10.1101/729269v1.full.pdf> [retrieved on 20210122], DOI: 10.1101/729269 * |
Also Published As
Publication number | Publication date |
---|---|
WO2021042062A2 (en) | 2021-03-04 |
US20220290121A1 (en) | 2022-09-15 |
WO2021042062A3 (en) | 2021-04-08 |
EP4021945A2 (en) | 2022-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4021945A4 (en) | Combinatorial adenine and cytosine dna base editors | |
EP3921417A4 (en) | Adenine dna base editor variants with reduced off-target rna editing | |
EP3728575A4 (en) | Cas12b systems, methods, and compositions for targeted dna base editing | |
EP3917497A4 (en) | Oligonucleotide compositions and methods thereof | |
EP4028026A4 (en) | Novel nucleobase editors and methods of using same | |
EP4051788A4 (en) | Type v crispr-cas base editors and methods of use thereof | |
EP3686275A4 (en) | Gene editing t cell and use thereof | |
EP4000070A4 (en) | Phase-aware determination of identity-by-descent dna segments | |
EP3623462A4 (en) | Gene sequencing chip and gene sequencing method | |
EP4007818A4 (en) | Methods and reagents for nucleic acid sequencing and associated applications | |
EP3940078A4 (en) | Off-target single nucleotide variants caused by single-base editing and high-specificity off-target-free single-base gene editing tool | |
EP4031190A4 (en) | Highly efficient dna base editors mediated by rna-aptamer recruitment for targeted genome modification and uses thereof | |
EP3750561A4 (en) | Skin-permeating carrier containing nucleic acid complex and use thereof | |
EP3581652A4 (en) | Pcr primer set for hla gene, and sequencing method using same | |
EP3998354A4 (en) | Genetic marker combination and application thereof | |
EP3843790A4 (en) | Nucleic acid constructs comprising gene editing multi-sites and uses thereof | |
EP3950960A4 (en) | Dna methylation marker for predicting recurrence of liver cancer, and use thereof | |
EP3839070A4 (en) | Dna methylation-related marker for diagnosing tumor, and application thereof | |
EP3901287A4 (en) | Novel dna aptamer and use thereof | |
EP3740591A4 (en) | Mutant dna polymerases | |
IL284717A (en) | Double stranded rna and uses thereof | |
EP4117682A4 (en) | Modified nucleotides and uses thereof | |
EP3418289A4 (en) | Artificial nucleoside and artificial nucleotide, and artificial oligonucleotide | |
EP4010486A4 (en) | Single nucleotide polymorphisms and uses thereof | |
EP3947674A4 (en) | Methods, systems, and aparatus for nucleic acid detection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20220330 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: C07K0019000000 Ipc: C12N0015100000 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20231013 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 15/62 20060101ALI20231009BHEP Ipc: C12N 15/55 20060101ALI20231009BHEP Ipc: C12N 15/11 20060101ALI20231009BHEP Ipc: C12N 9/22 20060101ALI20231009BHEP Ipc: C12N 9/16 20060101ALI20231009BHEP Ipc: C07K 19/00 20060101ALI20231009BHEP Ipc: C12N 15/10 20060101AFI20231009BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |